According to a Blue Health Intelligence study, those who receive prescriptions from an endocrinologist or obesity specialist were more likely to continue and complete 12 weeks of treatment
Patients who continue high-calorie diets, particularly those rich in processed foods, added sugars, or caloric beverages (including alcohol), may experience blunted weight loss despite adequate glycemic improvement
10.1016/j.fct.2022.113481 264 YiY.WanS.WangS.KhanA.GuoJ.ZhengX.et al (2021)
Association between different GLP-1 receptor agonists and gastrointestinal adverse reactions:a real-world disproportionality study based on FDA adverse event reporting system database
This shared pathophysiology has led to several medical guidelines on the management of MASLD/MASH strongly recommending the use of glucagon-like peptide-1 (GLP-1) receptor agonist-based therapies, alone or in combination with sodiumglucose cotransporter 2 (SGLT2) inhibitors, as first-line therapeutic options for individuals with type 2 diabetes and MASLD [5, 17]
Severe reactions, though rare, may include infection or allergic response at the injection site